EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)
EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)
Recruiting · NCT06923761 · Registry updated 2026-01-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1) | Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, adenocarcinoma, carcinoma, cervix disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, head and neck squamous cell carcinoma, hepatocellular carcinoma, liver disorder, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, squamous cell carcinoma, uterine disorder | Recruiting | Phase 1 / Phase 2 | 2026-01-28 | NCT06923761 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Grey Wolf Therapeutics | 2 |
29 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.